GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Berry Genomics Co Ltd (SZSE:000710) » Definitions » EV-to-FCF

Berry Genomics Co (SZSE:000710) EV-to-FCF : 64.52 (As of May. 23, 2024)


View and export this data going back to 1997. Start your Free Trial

What is Berry Genomics Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Berry Genomics Co's Enterprise Value is ¥3,155 Mil. Berry Genomics Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ¥49 Mil. Therefore, Berry Genomics Co's EV-to-FCF for today is 64.52.

The historical rank and industry rank for Berry Genomics Co's EV-to-FCF or its related term are showing as below:

SZSE:000710' s EV-to-FCF Range Over the Past 10 Years
Min: -29694.74   Med: -51.13   Max: 1268.39
Current: 64.52

During the past 13 years, the highest EV-to-FCF of Berry Genomics Co was 1268.39. The lowest was -29694.74. And the median was -51.13.

SZSE:000710's EV-to-FCF is ranked worse than
82.7% of 370 companies
in the Biotechnology industry
Industry Median: 9.66 vs SZSE:000710: 64.52

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-23), Berry Genomics Co's stock price is ¥8.56. Berry Genomics Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-1.130. Therefore, Berry Genomics Co's PE Ratio for today is At Loss.


Berry Genomics Co EV-to-FCF Historical Data

The historical data trend for Berry Genomics Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Berry Genomics Co EV-to-FCF Chart

Berry Genomics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -74.54 272.50 -28.40 -78.34 72.53

Berry Genomics Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,073.51 -264.76 338.14 72.53 69.07

Competitive Comparison of Berry Genomics Co's EV-to-FCF

For the Biotechnology subindustry, Berry Genomics Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Berry Genomics Co's EV-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Berry Genomics Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Berry Genomics Co's EV-to-FCF falls into.



Berry Genomics Co EV-to-FCF Calculation

Berry Genomics Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=3155.053/48.902
=64.52

Berry Genomics Co's current Enterprise Value is ¥3,155 Mil.
Berry Genomics Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥49 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Berry Genomics Co  (SZSE:000710) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Berry Genomics Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=8.56/-1.130
=At Loss

Berry Genomics Co's share price for today is ¥8.56.
Berry Genomics Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-1.130.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Berry Genomics Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Berry Genomics Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Berry Genomics Co (SZSE:000710) Business Description

Traded in Other Exchanges
N/A
Address
Life Park Road, Building 5, Courtyard 4, Science and Technology Park, Changping District, Beijing, CHN
Berry Genomics Co Ltd is an innovative biotechnology company. It providess gene sequencing detection equipment and services.

Berry Genomics Co (SZSE:000710) Headlines

No Headlines